A Study of MSB0254 Injection in Advanced Solid Tumors
Clinical trial NCT04381325 · TERMINATED
Trial details
- NCT number
- NCT04381325
- Sponsor
- Suzhou Transcenta Therapeutics Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2022-06-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.